To overcome this problem, different markers, such as vimentin, αSMA, PDGFRα/β, and fibroblast activation protein α (FAP), are used in combination to identify all the different subpopulations of CAFs in the tumor [14]. This evidence concerns the gene ACTA1 and neoplasm.